Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio (QoQ) (2011 - 2025)
Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100.02% |
| Sep 30, 2025 | -2,451.06% |
| Jun 30, 2025 | 2,213.45% |
| Mar 31, 2025 | -149.97% |
| Dec 31, 2024 | -98.62% |
| Sep 30, 2024 | 6,895.57% |
| Jun 30, 2024 | 792.60% |
| Mar 31, 2024 | 62.90% |
| Jun 30, 2023 | -1,390.79% |
| Mar 31, 2023 | -54.79% |
| Dec 31, 2022 | 168.78% |
| Sep 30, 2022 | 713.43% |
| Jun 30, 2022 | 477.59% |
| Mar 31, 2022 | -97.45% |
| Dec 31, 2021 | -81.33% |
| Sep 30, 2021 | -11.81% |
| Jun 30, 2021 | 187.91% |
| Mar 31, 2021 | -69.27% |
| Dec 31, 2020 | -23.51% |
| Mar 31, 2020 | 149.38% |